WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China's Online Pharmacy Market Surpasses CNY 70B: WMs Gain Ground as Domestic ... In 2024, China's online pharmacy market achieved a historic milestone, with total drug sales—spanning TCMs, chemical drugs, and biologics—surpassing CNY 71.5 billion fo...
(4/14/2025)

Chinese drugmakers weigh options as US mulls p... (4/18/2025)

Interpretation of the Anti-Monopoly Guidelines... (4/17/2025)

This Pharma Company Is Betting Big On A Chines... (4/17/2025)

Off-Label Drug Use in China After the Physicia... (4/15/2025)

China's Online Pharmacy Market Surpasses CNY 7... (4/14/2025)

Trump vs China Biotech: Who Will Emerge Victor... (4/14/2025)

NIH Ban Disrupts Some Chinese Genetics Researc... (4/8/2025)

Analysis of China-to-West Pharmaceutical Licen... (4/5/2025)

China Biopharma Financing Tracker, Q1 2025 (MC... (4/5/2025)

China Biopharma Licensing Tracker, Q1 2025 (MC... (4/5/2025)

China's Pharma Industry Shows Signs of Recover... (4/1/2025)

China Releases Draft Implementation Measures f... (3/28/2025)

VelaVigo and Ollin Biosciences Ink ex-Gr... (4/18/2025) Pharma Giants Already Moving to Cut Reli... (4/17/2025) WuXi AppTec Cashes Out of WuXi XDC as U.... (4/17/2025) Eddingpharm to Take Over Genor in HKEX's... (4/17/2025) Latticon Pioneers China's First Pipeline... (4/17/2025) Hengrui Advances CD79b-Targeted ADC SHR-... (4/17/2025) Sanofi Secures Global Rights to AI-Disco... (4/17/2025) Akeso Advances Second ADC into Clinical ... (4/17/2025) Eli Lilly's Mirikizumab Advances in Chin... (4/17/2025) InnoCare's Zurletrectinib NDA Accepted b... (4/17/2025) DualityBio Raises $211M in Hong Kong IPO (4/17/2025) BMS Launches Head-to-Head Phase 1 Trial ... (4/17/2025) Akeso Initiates First Clinical Trial for... (4/15/2025) U.S. Tariff Threat on Chinese Pharma Cou... (4/15/2025) Chinese Pharma Companies Rethink Global ... (4/15/2025) China NMPA Approves Kowa's Parmodia (Pem... (4/15/2025) Gardasil9 Gains Expanded Approval in Chi... (4/15/2025) Belief BioMed/Takeda's hemophilia B Gen... (4/14/2025)

China Unveils Ambitious Plan to Boost Health-Related Co... Chinese VMS OTC Market Growth Slowed to 2.7% in 2024 Newish Tech Secures Series B Financing to Advance Next-... China's Retail Pharmacy Market Reaches CNY 574 Billion ... China's Pharmaceutical Market Shrinks in 2024 Amid Stru...

VelaVigo and Ollin Biosciences Ink ex-Greater China Lic... BMS Launches Head-to-Head Phase 1 Trial for SystImmune-... DualityBio Raises $211M in Hong Kong IPO Sanofi Secures Global Rights to AI-Discovered BsAb in $... Hengrui Advances CD79b-Targeted ADC SHR-A1912 into Phas...

China Revises Military Drug Administration Measures to ... CDE Solicits Comments on Draft Q&A for CMC Issues in r... NMPA Solicits Comments on the Announcement on Matters R... NMPA Mandates Digital QR Code System for Drug Manufactu... China Receives 2.6 Million ADR Reports in 2024, Severe ...

NHC Ministers Meet with Top Pharma MNC Executives Beijing Unveils Ambitious Policy Package to Supercharge... China's BMI Fund Surpasses CNY16.5 Trillion with 11% An... Growing Awareness and Expanding Treatment Options for S... China Sets Ambitious Nutritional Targets for 2030 to Im...

Novo Nordisk Sues KBP Biosciences for $830 Million Over... State Council Releases Final Antitrust Guidelines for t... Bayer Initiates Patent Infringement Lawsuit Against Hen... Oxford Nanopore Sues Chinese Biotech Giant BGI Over All... Congress Debates Biosecure Act Amid Report Highlighting...

FDA Issues Warning Letters to Two Chinese API Manufactu... Implications of China's Growing Influence in Global Pha... FDA Issues Warning to Tianjin Darentang for Manufacturi... Shanghai Pharma Considers API Partnerships with Indian ... Aurobindo Challenges China in the Global Penicillin G M...

InnoCare's Zurletrectinib NDA Accepted by China's NMPA ... Eli Lilly's Mirikizumab Advances in China with New Indi... Akeso Advances Second ADC into Clinical Trials with TRO... Gardasil9 Gains Expanded Approval in China China NMPA Approves Kowa's Parmodia (Pemafibrate) for D...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...